About AMNIVOR Medicare
AMNIVOR Medicare is a company based in Kharagpur (India) founded in 2012 by Pallab Majumdar and Nilanjana Maiti Dhara. AMNIVOR Medicare operates in a competitive market with competitors including Imbed Biosciences, Sirnaomics, Liquidia, Acorda and Genedit, among others.
- Headquarter Kharagpur, India
- Founders Pallab Majumdar, Nilanjana Maiti Dhara
- SectorsTechnologyHealthcare
- Email••••••••
- Website amnivormedicare.com
- Legal Name Amnivor Medicare Private Limited
- Date of Incorporation 24 Dec, 2012
- Jurisdiction Marisdha, West Bengal, India
- Annual Revenue₹4.5 Lakh
FY 2024 · -78% YoY
- Net Loss-₹4.6 Lakh
FY 2024 · -102% margin
- EBITDA-₹1.1 Lakh
FY 2024 · -25% margin
Associated legal entities of AMNIVOR Medicare
AMNIVOR Medicare operates through Amnivor Medicare Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Amnivor Medicare Private Limited CIN U85100WB2012PTC189496 | Active | 24 Dec 2012 | Marisdha, West Bengal | ₹0.0 Cr | – | 2 | View details |
Board of directors of Amnivor Medicare Private Limited (AMNIVOR Medicare)
Amnivor Medicare Private Limited is the primary company behind AMNIVOR Medicare. The board of Amnivor Medicare Private Limited currently have 2 directors; the longest-serving is Santanu Dhara, appointed in 2012. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Santanu Dhara DIN 06404015 | Director | 24 Dec 2012 | 13 yrs 9 mo | Amnivor Medicare Private Limited |
| Nilanjana Maiti Dhara DIN 06643482 | Director | 07 Jul 2013 | 13 yrs 3 mo | Amnivor Medicare Private Limited |
People of AMNIVOR Medicare
2 people are tracked at AMNIVOR Medicare (2 in leadership).
| Name | Role | Group |
|---|---|---|
Pallab Majumdar | Co-Founder | Leadership |
| Co-Founder | Leadership |
Complete people profiles for AMNIVOR Medicare
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of AMNIVOR Medicare
Figures of Amnivor Medicare Private Limited, the primary company behind AMNIVOR Medicare, for FY 2024. Revenue was ₹4.5 Lakh (-78% year on year). Net loss was -₹4.6 Lakh (-102% margin). EBITDA was -₹1.1 Lakh (-25% margin).
- ₹4.5 LakhRevenue · FY 2024 · -78% YoY
- -₹4.6 LakhNet loss · -102% margin
- -₹1.1 LakhEBITDA · -25% margin
- ₹3 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Amnivor Medicare Private Limited are on its company page.
Detailed financial statements for AMNIVOR Medicare
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of AMNIVOR Medicare
AMNIVOR Medicare operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Imbed Biosciences, Sirnaomics, Liquidia, Acorda and Genedit, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| imbedbio.com | 2010 | Madison, United States | $22.7M | 35 | Nanotech-based wound care products are developed and provided. | |
| sirnaomics.com | 2007 | Gaithersburg, United States | $267M | 88 | RNA-based therapeutics for cancer and fibrosis are developed. | |
| liquidia.com | 2004 | United States | $75.3M | 63 | Engineered particles & films for life and material sciences applications | |
| acorda.com | 1995 | Ardsley, United States | $66.5M | 109 | Engaged in the development and commercialization of therapies that improve neurological function. | |
| genedit.com | 2016 | Berkeley, United States | $93.5M | 34 | Genetic medicines are delivered using polymer nanoparticle platforms. | |
| nanosyrinx.com | 2018 | Coventry, United Kingdom | $21.63M | 17 | Drug delivery systems to cell interiors are developed via nanosyringes. | |
| ensysce.com | 2008 | Houston, United States | $2.5M | – | Drug delivery solutions via single-walled carbon nanotubes are offered. | |
| arcturusrx.com | 2013 | San Diego, United States | $1.3M | 337 | RNAi technologies are developed for treating rare orphan diseases. | |
| clene.com | 2012 | Salt Lake, United States | $59.1M | 99 | Nanotechnology-based therapeutics for cancer and auto-immune disorders are developed. | |
| erydel.com | 2007 | Milan, Italy | $31.7M | – | Erythrocyte encapsulation systems for drug delivery are developed. |
Detailed competitors of AMNIVOR Medicare
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to AMNIVOR Medicare
10 companies that operate in the same segment as AMNIVOR Medicare (Nanotechnology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Developer of technologies for analysis of genetic variation and function | 1993 | San Diego, California, United States | USD 28 M | USD 1.44 M | 29 | |
RNA interference-based therapeutics are developed for multiple disorders. | 2002 | Cambridge, Massachusetts, United States | USD 17 M | USD 3.71 B | 2,230 | |
Technology tools and systems for molecular scale are developed. | 1959 | Abingdon, Oxfordshire, United Kingdom | – | USD 648.1 M | – | |
Aerogel-based thermal insulation solutions are provided for energy conservation. | 2001 | United States | USD 198.35 M | USD 271.1 M | 554 | |
Nanotech-based electrode materials for supercapacitors are provided. | 2009 | Boston, Massachusetts, United States | USD 163.32 M | – | 66 | |
Instrument systems and software for single-molecule real-time sequencing are developed. | 2004 | Menlo Park, California, United States | USD 395 M | USD 160 M | 575 | |
Nanotech-based wound care products are developed and provided. | 2010 | Madison, Wisconsin, United States | USD 22.7 M | – | 35 | |
Conductive nanocoatings are delivered via atomic layer deposition technology. | 2013 | Boulder, Colorado, United States | USD 202.75 M | – | – | |
RNA therapeutics for hematology and cardiovascular diseases are developed. | 1999 | London, England, United Kingdom | – | USD 559 K | 116 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AMNIVOR Medicare
AMNIVOR Medicare was founded in 2012.
AMNIVOR Medicare is headquartered in Kharagpur, India. It is registered at Kharagpur, West Bengal, India.
The primary company behind AMNIVOR Medicare, Amnivor Medicare Private Limited, reported revenue of ₹4.5 Lakh for FY 2024, down 78% year on year.
The company was founded in 2012 in Kharagpur, India, within the healthcare nanotechnology sector. A technology for extracting collagen from freshwater fish scales has been developed, utilizing an abundant and cost-effective resource. Collagen and related products are manufactured at a facility on the IIT-Kharagpur campus. These products are applied in treatments for diabetes, burns, trauma, and chronic wounds.
AMNIVOR Medicare's top competitors include Imbed Biosciences, Sirnaomics and Arcturus Therapeutics.
AMNIVOR Medicare operates through Amnivor Medicare Private Limited.
The legal entities of AMNIVOR Medicare currently have 2 directors, including Santanu Dhara, Nilanjana Maiti Dhara.